Showing 2 posts of 2 posts found.

Immodulon appoints Josefine Roemmler-Zehrer as chief medical officer

June 20, 2023
Immodulon, Josefine Roemmler-Zehrer, appointment, chief medical officer

Cancer immunotherapy company Immodulon has announced that it has appointed Josefine Roemmler-Zehrer as chief medical officer, bringing with her vast …


Dr James Shannon joins Immodulon Therapeutics board of directors

July 29, 2015
Research and Development, Sales and Marketing Immodulon

Dr James Shannon has joined Immodulon as a non-executive director with immediate effect. Bringing with him 30 years’ of experience …

Latest content